Startup Profile: Lactiga (020)

Episode 20 September 05, 2021 00:48:50
Startup Profile: Lactiga (020)
Innovation4Alpha
Startup Profile: Lactiga (020)

Sep 05 2021 | 00:48:50

/

Show Notes

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. They are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including Covid. Lactiga has earned multiple awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.

AngelMD Profile: https://www.angelmd.co/en/startups/lactiga

Other Episodes

Episode 4

January 24, 2022 00:18:47
Episode Cover

David Finkel Founder/CEO of Maui Mastermind - (Part 3) (204)

Listen

Episode 27

July 30, 2022 00:29:03
Episode Cover

Ai Medica: Turbo-charging EHRs for Better Outcomes & More (227)

Ai Medica makes it easy to create clinical and economic value from EHR data using evidence based medicine. They have built a platform on...

Listen

Episode 27

August 16, 2022 00:33:14
Episode Cover

Star Harbor: Accelerating innovation through space education, training and research (228)

Maraia Tanner is the CEO of Star Harbor based in Lone Tree, Colorado. She shares insights into the mission of the organization and how...

Listen